Apr 14, 2021 | Articles, CLIA, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
EDP Biotech Finalist in MedCity INVEST Pitch Perfect Diagnostic Track In the age of COVID, diagnostics have become more valuable than ever. EDP Biotech has been fortunate to advance diagnostic programs in colorectal cancer and COVID testing during the last year, and...
Mar 2, 2021 | Articles, Clinical Trials, COVID-19, Featured, News and Events
INSFRASTRUCTURE, TECHNOLOGY AND REGULATION FOR DCTs In this presentation, we discuss how decentralized clinical trials provide better patient engagement by removing common barriers that can have a negative impact on recruitment and retention. We examine various...
Jan 8, 2021 | COVID-19, Featured, News and Events
EDP Biotech to compete in 2021 Tennessee Titans Pitch for Good! The Tennessee Titans and Nashville Entrepreneur Center (NEC) have launched a collaborative partnership to identify and honor Nashville’s top entrepreneur/small business. The Pitch for Good:...
Dec 8, 2020 | Articles, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
NOLABA, Partners Name Winners of Health Innovators Challenge Watch the YouTube video above to hear EDP Biotech and other NOLABA Challenge winners discuss their impact in healthcare. Read full Article on BizNewOrleans.com “The third challenge was a unique...
Nov 3, 2020 | CLIA, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
EDP Biotech pitches last week, participating in two upcoming events in November ON OCTOBER 26 TH, 2020 BY TOM BALLARD Eric Mayer, Chief Executive Officer of EDP Biotech Corporation, alerted us to several important events for the company. One was last week during...
Oct 1, 2020 | Antibody, COVID-19, Featured, News and Events
Innov865 2020 Impact Awards Teaser Although Knoxville’s Innov865 Startup Day 2020 is virtual this year, the excitement surrounding this year’s Awards Ceremony is building around those entrepreneurs making a difference in the midst of a global pandemic....
